Li, R., Kamat, A. M., Necchi, A., Banerjee, J. K., Keidel, S., Huang, D., Davis, N. B., Grivas, P. (2026). Intismeran autogene (V940/mRNA-4157) plus bacillus Calmette-Guérin (BCG) versus BCG alone for high-risk non–muscle-invasive bladder cancer: The phase 2 INTerpath-011 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps882